Q: Good afternoon,
Eli Lilly has fallen by nearly 20% in two days after its phase 3 trial Alzheimer's flopped. Do you think there is a good buying opportunity here? Would you step in?
Thx,
KR
Eli Lilly has fallen by nearly 20% in two days after its phase 3 trial Alzheimer's flopped. Do you think there is a good buying opportunity here? Would you step in?
Thx,
KR